- Home
- NTIP vs EKSO Comparison
NTIP vs EKSO Comparison
Compare NTIP & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTIP | EKSO |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 37.9M |
| IPO Year | 2013 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NTIP | EKSO |
|---|---|---|
| Price | $1.40 | $11.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | ★ 491.2K | 57.0K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.90% | N/A |
| EPS Growth | 15.38 | ★ 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $150,000.00 | N/A |
| Revenue This Year | N/A | $81.23 |
| Revenue Next Year | N/A | $7.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 50.00 | N/A |
| 52 Week Low | $1.16 | $0.23 |
| 52 Week High | $1.75 | $13.50 |
Technical Indicators
Market Signals| Indicator | NTIP | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 56.22 |
| Support Level | $1.34 | $8.30 |
| Resistance Level | $1.47 | $13.16 |
| Average True Range (ATR) | 0.11 | 0.85 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 27.08 | 78.36 |
Price Performance
Historical ComparisonAbout NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.